Several analysts have recently updated their ratings and price targets for GE HealthCare Technologies, impacting the stock price.
Stock AI’s forecasts:
🔴 -7.0% short-term ⬇️
🟢 +1.4% long-term ⬆️
Stock AI’s (GEHC) Forecast get (+10.1% Profit)
StockAI’s analysis delivers real-world results. On 08 March 2024, $GEHC ($93.9), StockAI predicted a long-term 🔴 sell signal. It was accurate: 1 month later price dropped to $84.4 (🔴-10.1%). Selling GEHC on this signal yielded a +10.1% profit 💰💰.
GEHC-GE HealthCare Technologies Inc. News
🟢 GE HealthCare Technologies had its price target raised by Mizuho from $96.00 to $110.00, with a “buy” rating.
🟢 Citigroup increased GEHC’s target price from $88.00 to $103.00 and maintained a buy rating on the stock.
🔴 GEHC reported first-quarter sales of $4.6 billion, down 1% Y/Y, missing the consensus of $4.8 billion.
🔴 Revenues declined 1% Y/Y; Organic revenue growth was approximately flat.
🔴 Deutsche Bank downgraded Honeywell, citing its massive portfolio of businesses as a problem.
🔴 Several analysts updated their ratings and price targets for GEHC.
Recent news for GE HealthCare Technologies Inc. stock has been a mix of positive and negative developments. While some analysts have raised price targets and maintained buy ratings, the company reported a decline in first-quarter sales and revenues. The negative impact of these financial results, along with the downgrade of a related company by Deutsche Bank, may lead to a decrease in the stock price in the short term. However, the positive ratings and price target increases could provide some support and potentially lead to a slight increase in the long-term forecast. Investors should closely monitor the ongoing news and developments surrounding GEHC to make informed decisions about their investment strategies.
GEHC-GE HealthCare Technologies Inc. Analyst Ratings
In recent weeks, analysts have been closely monitoring and updating their ratings for GE HealthCare Technologies Inc. stock. Here is a brief list of some of the recent analyst ratings:
📈 Mizuho raised their price target for GEHC from $96.00 to $110.00 and maintained a “buy” rating.
📉 Citigroup increased their target price for GEHC from $88.00 to $103.00 but kept a buy rating on the stock.
📈 Argus raised their price target for GEHC from $80.00 to $110.00 and maintained a “buy” rating.
These are just a few of the recent analyst ratings that have been updated for GE HealthCare Technologies Inc. stock. It is important for investors to stay informed about these changes as they can have an impact on stock performance.
Sources:
1. ETF Daily News
2. ETF Daily News
3. ETF Daily News
4. Market Screener
5. CNBC
Disclaimer
Investors may consider the AI predictions and news summaries as one factor in their investment decisions alongside their own research and risk tolerance.
Ready to analyze your own portfolio?
Get the same AI-powered insights for any stock you choose. It's easy!
